In the LIBERATE-D trial, patients in the conservative dialysis group underwent dialysis only when meeting criteria such as serum urea nitrogen >112 mg/dL, hyperkalemia >6 mmol/L, metabolic acidosis with pH <7.15, severe pulmonary edema causing significant hypoxemia, or clinician judgment.